XML 104 R91.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information - Schedule of Sales by Therapeutic Category (Detail) - Sales Revenue, Net [Member] - Product Concentration Risk [Member]
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 100.00% 100.00% 100.00%
Dermatological and Topical [Member]      
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 60.00% 58.00% 63.00%
Neuropsychiatric [Member]      
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 13.00% 16.00% 17.00%
Cardiovascular [Member]      
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 6.00% 7.00% 6.00%
Anti-Inflammatory [Member]      
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 3.00% 3.00% 3.00%
Other [Member]      
Schedule Of Sales Revenue By Business Segment [Line Items]      
Net sales 18.00% 16.00% 11.00%